Tainted Blood Pressure Meds Get Recalled
Aurobindo Pharma USA Recall
A pharmaceutical firm recently started a recall for blood pressure medication. Apparently, the drug was found to have trace amounts of a chemical that is known to cause cancer. The FDA made an announcement that the Aurobindo Pharma USA, INC. company has plans to recall 80 lots of Amlodipine Valsartan, Valsartan HCTZ and Valsartan all in the tablet form.
The chemical found is call N-nitrosodiethylamine or NDEA and is naturally found in drinking water, foods, industrial processes, and air pollution. Despite any natural occurrences of this drug, the FDA classifies it as a probable human carcinogen. Even though there have not been any reports of adverse effects, the recall will still be enforced.
Similar Concerns over NDEA were reported last month when traces of NDEA were recalled when the company Torrent Pharmaceuticals Limited issued a recall of two lots of its products. Also, in November Mylan Pharmaceutical issued recalls for the same reason. So, what does this mean? There hasn’t been any reporting of any deaths and cancer hasn't been proved a result of taking these medications. We will have to wait and see if there are any adverse effects in the near future. If you are prescribed to these drugs it is urgently recommended that you do not stop your normal dosage until you have consulted your doctor and already have a medication to replace your Valsartan.
More information about recalls can found on the FDA’s website here.
New Recall Issued On Blood Pressure Medication
CBS News. (2019, January 02). Another blood pressure medication recalled over trace amounts of cancer-causing chemical. Retrieved January 2, 2019, from https://www.cbsnews.com/news/blood-pressure-medication-recall-aurobindo-pharma-valsartan-amlodipine-trace-amounts-carcinogen-chemical-ndea/
© 2019 James Smith